Cipla Limited (CIPLA) — Corporate Action | 31 July 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Allotment of 7,850 equity shares under ESOS and ESAR schemes
🔄 What Changed
Paid-up share capital increased to INR 1,61,57,06,332
💡 Investor Takeaway
This issuance dilutes existing shareholders' ownership percentage.

Cipla announced the allotment of 7,850 fully paid-up equity shares of INR 2 each under its ESOS 2013-A and Cipla ESAR Scheme 2021, increasing the paid-up share capital to INR 1,61,57,06,332 comprising 80,78,53,166 shares of INR 2 each.

📄 View Original Announcement (PDF)

About Cipla Limited (CIPLA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,15,682.55 Cr P/E: 25.4 ROE: 14.6% ROCE: 19.4%

View full CIPLA stock details →

📡 Get AI alerts when CIPLA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CIPLA — Free

📊 More CIPLA filings

See all CIPLA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CIPLA files new disclosures

Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CIPLA — Free

Free account · 2 AI queries/day